What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Snake Inclusion Body Disease: Testing, Isolation, and Collection Management

At a Glance

Inclusion body disease (IBD) is a viral disease of boid snakes caused by reptarenaviruses. This article provides veterinarians and collection managers with diagnostic testing strategies, isolation protocols, and long-term collection management approaches for IBD in boas and pythons. The table below summarizes key diagnostic and management considerations.

Aspect	Key Consideration	Practical Implication
Diagnostic testing	PCR on whole blood, liver, kidney, or spleen samples	Antemortem testing has lower sensitivity than postmortem tissue sampling
Isolation duration	Minimum 90 days for new arrivals	Extended quarantine reduces risk of introducing reptarenavirus into established collections
Collection management	Test all boid snakes annually	Early detection allows removal of positive animals before clinical signs develop
Biosecurity	Dedicated equipment and separate housing for each snake group	Fomite transmission is suspected based on cell culture experiments

Disease Etiology and Pathogenesis

Inclusion body disease is associated with reptarenaviruses, a group of segmented negative-sense RNA viruses in the family Arenaviridae. The disease primarily affects boid snakes, including boas and pythons. Cell culture co- and superinfection experiments suggest that transmission during captivity contributes to the presence of reptarenavirus S and L segment swarms in boid inclusion body disease-positive snakes (Cell culture co- and superinfection experiments suggest that transmission during captivity contributes to the presence of reptarenavirus S and L segment swarms in boid inclusion body disease-positive snakes, Journal of General Virology, 2024, PubMed). This finding indicates that multiple viral strains can circulate within a single collection and that transmission events during captivity drive genetic diversity of the virus.

The pathogenesis of IBD involves viral replication in multiple organ systems, with characteristic eosinophilic intracytoplasmic inclusion bodies forming in various tissues. Experimental Reptarenavirus Infection of Boa constrictor and Python regius demonstrated that infection can be established experimentally, confirming the causal relationship between reptarenavirus and IBD (Experimental Reptarenavirus Infection of Boa constrictor and Python regius, Journal of Virology, 2021, PubMed). The incubation period varies widely, ranging from weeks to years, which complicates detection and control efforts.

Clinical Signs and Disease Presentation

Clinical signs of IBD in boid snakes are variable and nonspecific. Common presentations include regurgitation, anorexia, weight loss, neurologic signs such as head tremors, incoordination, and opisthotonos, as well as chronic respiratory infections. Some snakes remain subclinical carriers for extended periods. Reptarenaviruses in apparently healthy snakes in an Australian zoological collection documented reptarenavirus detection in snakes without clinical signs, highlighting the importance of routine screening (Reptarenaviruses in apparently healthy snakes in an Australian zoological collection, Australian Veterinary Journal, 2019, PubMed). This finding underscores that absence of clinical signs does not rule out infection.

In boas, the disease often follows a chronic progressive course, while pythons may develop more acute disease with rapid deterioration. Neurologic signs are more commonly reported in pythons. The Merck Veterinary Manual provides general guidance on reptile diseases and should be consulted for additional clinical context (Merck Veterinary Manual, Merck Veterinary Manual). The World Organisation for Animal Health also addresses animal health and welfare standards relevant to infectious disease management in captive collections (Animal Health and Welfare, World Organisation for Animal Health).

Diagnostic Testing Options

Polymerase Chain Reaction Testing

PCR testing is the primary antemortem diagnostic tool for reptarenavirus detection. Whole blood samples are commonly used, but sensitivity is higher when testing liver, kidney, or spleen tissue obtained postmortem. The Association of Reptilian and Amphibian Veterinarians provides resources on reptile diagnostics and should be consulted for current testing recommendations (ARAV, Association of Reptilian and Amphibian Veterinarians).

PCR testing detects viral RNA and can identify both S and L genome segments. The presence of segment swarms, as described in cell culture experiments, means that testing for multiple genomic targets may improve detection sensitivity. Samples should be collected using aseptic technique and shipped to a laboratory experienced in reptarenavirus testing.

Histopathology

Histopathologic examination of tissue biopsies or postmortem samples can identify characteristic eosinophilic intracytoplasmic inclusion bodies. Liver, kidney, pancreas, and brain are common target tissues. Inclusion bodies are not pathognomonic for IBD, as similar structures can occur in other conditions, but their presence in conjunction with clinical signs and PCR results supports the diagnosis.

Histopathology is most useful as a confirmatory test following PCR screening or when PCR results are equivocal. It also provides information about the extent of tissue damage and concurrent disease processes.

Virus Isolation

Virus isolation in cell culture is possible but is not routinely performed for clinical diagnosis. In vitro isolation and molecular identification of reptarenavirus in Malaysia demonstrated successful isolation from clinical samples (In vitro isolation and molecular identification of reptarenavirus in Malaysia, Virus Genes, 2016, PubMed). This technique is primarily used for research purposes and to characterize viral strains.

Metagenomic Sequencing

Metagenomic sequencing is an emerging diagnostic approach that can detect reptarenavirus without prior knowledge of the specific viral sequence. Unbiased Virus Detection in a Danish Zoo Using a Portable Metagenomic Sequencing System demonstrated the utility of this approach for detecting reptarenavirus in zoo collections (Unbiased Virus Detection in a Danish Zoo Using a Portable Metagenomic Sequencing System, Viruses, 2023, Elsevier). This method may become more accessible as sequencing technology advances.

Testing Protocols and Sample Collection

Antemortem Testing

For antemortem testing, collect 0.5 to 1.0 mL of whole blood from the ventral tail vein or other accessible vein. Place blood in an EDTA tube and refrigerate immediately. Ship samples on cold packs to the testing laboratory within 24 hours. Hemolyzed samples may reduce PCR sensitivity.

Oral swabs and cloacal swabs have lower sensitivity than blood samples and are not recommended as primary testing methods. However, they may be used in combination with blood testing in research settings.

Postmortem Testing

Postmortem testing provides the highest diagnostic sensitivity. Collect samples from liver, kidney, spleen, and brain. Place each tissue in a separate sterile container and freeze at -20°C or colder. Ship on dry ice to the testing laboratory. Formalin-fixed tissues can be used for histopathology but are not suitable for PCR.

Testing Frequency

Test all boid snakes in the collection annually. Test new arrivals at entry and again at 90 days post-arrival. Test any snake showing clinical signs consistent with IBD immediately. Test snakes that have been exposed to a confirmed positive animal at 30, 60, and 90 days post-exposure.

Isolation Protocols

Quarantine for New Arrivals

All new boid snakes should undergo a minimum 90-day quarantine period in a separate room or building from the main collection. The quarantine area should have dedicated equipment, including feeding tools, water bowls, and cleaning supplies. Use separate clothing and footwear when working in quarantine, or use disposable coveralls and boot covers.

Identification of snake arenaviruses in live boas and pythons in a zoo in Germany documented reptarenavirus detection in zoo collections, emphasizing the need for rigorous quarantine protocols (Identification of snake arenaviruses in live boas and pythons in a zoo in Germany, Tierarztliche Praxis Ausgabe K Kleintiere/Heimtiere, 2015, PubMed). Quarantine should include PCR testing at entry and at the end of the quarantine period.

Isolation of Suspect or Confirmed Cases

Any snake with clinical signs consistent with IBD or a positive PCR result should be immediately isolated from all other snakes. Use a separate room with negative air pressure relative to adjacent areas if possible. Dedicate equipment to the isolation area and do not share between enclosures.

Isolation should continue until diagnostic testing confirms negative status or until the animal is removed from the collection. For confirmed positive snakes, isolation may be indefinite if the animal is maintained for research or educational purposes, but this requires strict biosecurity measures.

Biosecurity Measures

Reptarenaviruses are suspected to be transmitted through direct contact, aerosol, and fomites. Cell culture experiments suggest that transmission during captivity contributes to viral diversity, indicating that environmental contamination may play a role. Implement the following biosecurity measures:

Use separate equipment for each snake or group of snakes
Disinfect enclosures and equipment with appropriate disinfectants effective against enveloped viruses
Use hand hygiene protocols between handling different snakes
Restrict access to snake housing areas to essential personnel only
Maintain records of all movements of snakes and equipment

Collection Management Strategies

Screening Programs

Implement annual screening of all boid snakes in the collection. Prevalence of viral infections in captive collections of boid snakes in Germany documented reptarenavirus prevalence in captive collections, supporting the need for routine surveillance (Prevalence of viral infections in captive collections of boid snakes in Germany, Veterinary Record, 2010, PubMed). Screening should include PCR testing of whole blood samples.

Maintain a database of testing results for each snake, including dates, sample types, and results. This database allows tracking of infection status over time and identification of new infections.

Management of Positive Animals

When a snake tests positive for reptarenavirus, the veterinarian should discuss management options with the collection manager. Options include euthanasia, permanent isolation, or removal from the collection. Euthanasia is recommended for clinically affected snakes due to the progressive nature of the disease and the risk of transmission to other snakes.

For subclinical carriers maintained for research or educational purposes, implement strict biosecurity measures and test all in-contact snakes. Consider removing all positive animals from the collection to eliminate the virus from the facility.

Preventing Introduction

Preventing introduction of reptarenavirus into a collection is more effective than managing an outbreak. Source snakes from reputable suppliers that test their collections. Quarantine all new arrivals for a minimum of 90 days and test at entry and exit from quarantine. Do not introduce snakes from unknown sources or from collections with known IBD history.

Records and Measurements

Testing Records

Maintain the following records for each snake:

Unique identification number
Species and subspecies
Date of acquisition and source
Dates and results of all PCR tests
Dates and results of histopathology if performed
Clinical signs observed and dates
Quarantine and isolation dates
Movement records within the facility

Collection Health Records

Maintain a collection-level health record that includes:

Total number of boid snakes in the collection
Number of snakes tested annually
Number of positive tests and species affected
Mortality and morbidity rates
Biosecurity incidents and corrective actions

Environmental Monitoring

Record environmental parameters in quarantine and isolation areas, including temperature, humidity, and ventilation rates. These records help identify conditions that may affect disease transmission or test sensitivity.

Common Failure Patterns

Inadequate Quarantine Duration

A common failure is shortening quarantine periods due to space constraints or pressure to introduce new animals. A 90-day minimum quarantine is necessary because the incubation period can be prolonged and PCR testing may not detect early infections. Shortening quarantine increases the risk of introducing reptarenavirus into the collection.

Insufficient Testing Frequency

Testing only at entry without a follow-up test at the end of quarantine misses infections that were acquired shortly before arrival or that have low viral loads early in infection. Annual testing of all boid snakes is necessary to detect new infections that may have occurred within the collection.

Cross-Contamination During Handling

Using the same equipment or handling snakes without hand hygiene between animals can transmit reptarenavirus. Dedicate equipment to each snake or group and implement strict hand hygiene protocols. Train all personnel on biosecurity procedures.

Failure to Test In-Contact Animals

When a positive snake is identified, testing only that animal without testing all in-contact snakes misses potentially infected animals. Test all snakes that shared housing, equipment, or handling personnel with the positive animal.

Reliance on Clinical Signs Alone

Waiting for clinical signs before testing allows subclinical carriers to spread the virus. Implement routine screening regardless of clinical status. Reptarenaviruses in apparently healthy snakes in an Australian zoological collection demonstrated that apparently healthy snakes can carry the virus.

Limitations and Considerations

Test Sensitivity and Specificity

PCR testing has high specificity but variable sensitivity depending on sample type and timing of collection. A negative PCR result does not rule out infection, particularly if the sample was collected early in infection or if viral load is low. Repeat testing at intervals is recommended for high-risk animals.

Species Differences

Boa constrictors and Python regius may differ in their susceptibility to reptarenavirus infection and disease progression. Experimental Reptarenavirus Infection of Boa constrictor and Python regius documented species-specific responses to experimental infection (Experimental Reptarenavirus Infection of Boa constrictor and Python regius, Journal of Virology, 2021, PubMed). Consider species-specific factors when interpreting test results and managing collections.

Subclinical Carriers

Subclinical carriers pose a significant challenge to collection management. These snakes can shed virus without showing clinical signs, making detection dependent on routine screening. The presence of subclinical carriers in a collection can maintain the virus in the population indefinitely.

Environmental Persistence

The persistence of reptarenavirus in the environment is not well characterized. Based on properties of other enveloped viruses, disinfection with appropriate agents is recommended. However, the exact duration of environmental contamination is unknown.

Professional Escalation Criteria

Urgent Escalation

Contact a veterinary specialist in reptile medicine or a diagnostic laboratory immediately if:

A snake develops acute neurologic signs consistent with IBD
Multiple snakes in the collection develop clinical signs simultaneously
A snake tests positive for reptarenavirus and has had contact with other snakes
A new arrival tests positive during quarantine

Routine Escalation

Consult with a veterinary specialist or diagnostic laboratory for:

Interpretation of equivocal PCR results
Development of a testing protocol for a new collection
Management of a collection with multiple positive snakes
Investigation of suspected false-positive or false-negative results

Reporting Requirements

Report confirmed cases of IBD to relevant animal health authorities as required by local regulations. The World Organisation for Animal Health provides guidance on animal health reporting (Animal Health and Welfare, World Organisation for Animal Health). Maintain documentation of all testing and management actions.

Practical Decision Framework for IBD Risk Classification and Response

Managing inclusion body disease in a boid snake collection requires consistent decision-making under uncertainty. Test results can be equivocal, incubation periods are variable, and subclinical carriers complicate risk assessment. This section provides a structured decision framework that integrates diagnostic findings, exposure history, and clinical status into actionable risk categories. The framework is designed for veterinarians and collection managers who need to make defensible decisions about isolation, testing frequency, and animal movement.

Risk Classification System

Classify each boid snake in the collection into one of four risk categories based on diagnostic test results, exposure history, and clinical signs. Reassess classification at each testing interval and whenever new information becomes available.

Low Risk: No known exposure to reptarenavirus, negative PCR result within the past 12 months, and no clinical signs consistent with IBD. These snakes can remain in the general collection with routine annual testing.

Moderate Risk: Known exposure to a confirmed positive snake within the past 90 days, or equivocal PCR result (weak positive or indeterminate), or clinical signs consistent with IBD but negative PCR result. These snakes require enhanced monitoring and repeat testing at 30-day intervals until reclassified.

High Risk: Positive PCR result on any sample type, or characteristic inclusion bodies on histopathology, or known exposure to a confirmed positive snake with clinical signs consistent with IBD. These snakes require immediate isolation and confirmatory testing.

Confirmed Positive: Positive PCR result confirmed by a second test on a different sample type or by histopathologic identification of inclusion bodies. These snakes require permanent isolation or removal from the collection.

Decision Matrix for Common Scenarios

The following decision matrix provides specific actions for common clinical scenarios. Each scenario assumes that the snake has been identified by unique identification number and that baseline health records are available.

Scenario 1: New arrival with negative entry PCR

Action: Place in quarantine for 90 days. Test at day 90. If negative, reclassify as low risk and move to general collection. If positive, reclassify as confirmed positive and implement isolation protocols.

Scenario 2: New arrival with positive entry PCR

Action: Confirm with a second PCR on a fresh blood sample collected 7 to 14 days after the first test. If confirmed positive, reclassify as confirmed positive. Do not introduce to general collection. Discuss euthanasia or permanent isolation with collection manager.

Scenario 3: Annual screening negative in a snake with no known exposure

Action: Maintain low risk classification. Continue annual testing. No change in management.

Scenario 4: Annual screening positive in a clinically normal snake

Action: Reclassify as high risk. Isolate immediately. Collect a second blood sample for confirmatory PCR. Test all in-contact snakes. If confirmed positive, reclassify as confirmed positive. If second test is negative, reclassify as moderate risk and repeat testing at 30 and 60 days.

Scenario 5: Snake with neurologic signs and negative PCR

Action: Reclassify as moderate risk. Isolate from general collection. Repeat PCR at 30 days. Consider histopathology of a biopsy sample if feasible. If PCR remains negative and clinical signs resolve, reclassify as low risk after 90 days. If PCR becomes positive, reclassify as confirmed positive.

Scenario 6: Snake with regurgitation and weight loss, PCR positive

Action: Reclassify as confirmed positive. Isolate immediately. Test all in-contact snakes. Discuss euthanasia with collection manager due to progressive clinical disease.

Scenario 7: Snake exposed to a confirmed positive snake within the past 30 days

Action: Reclassify as moderate risk. Test at exposure day 0, then at 30, 60, and 90 days post-exposure. Isolate from general collection until 90-day test is negative. If any test is positive, reclassify as confirmed positive.

Scenario 8: Multiple snakes in the same enclosure test positive

Action: Reclassify all snakes in the enclosure as high risk. Test all snakes that shared equipment or handling personnel. Implement enhanced biosecurity for the entire room or building. Consider depopulation of the affected enclosure.

Record System for Risk Classification

Maintain a centralized record system that tracks risk classification for each snake. The system should include the following fields for each animal:

Unique identification number
Species and subspecies
Current risk classification (low, moderate, high, confirmed positive)
Date of last classification
Basis for classification (test results, exposure history, clinical signs)
Date of next scheduled test
Quarantine or isolation status
Location within facility

Update the record system immediately whenever a snake changes classification. Generate monthly reports that summarize the number of snakes in each risk category, the number of tests performed, and the number of positive results. Review these reports with the collection manager to identify trends and adjust management protocols.

Escalation Criteria within the Decision Framework

The decision framework includes specific escalation criteria that trigger consultation with a veterinary specialist or diagnostic laboratory. These criteria are designed to prevent management errors when test results are ambiguous or when multiple snakes are affected.

Escalation to veterinary specialist:

Any snake classified as confirmed positive for the first time in a previously negative collection
Two or more snakes in the same room or building test positive within a 30-day period
A snake with clinical signs consistent with IBD has equivocal PCR results on two consecutive tests
A snake in isolation develops new clinical signs that suggest disease progression

Escalation to diagnostic laboratory:

PCR results that are inconsistent with clinical signs or exposure history
Suspected false-positive or false-negative results that cannot be resolved with repeat testing
Need for virus isolation or sequencing to characterize viral strains in the collection
Investigation of a suspected outbreak involving multiple snakes

Troubleshooting Common Decision Errors

Error 1: Reclassifying a snake from moderate to low risk too quickly

Correction: Maintain moderate risk classification for a minimum of 90 days after the last known exposure or after resolution of clinical signs. Premature reclassification increases the risk of introducing reptarenavirus into the general collection.

Error 2: Relying on a single negative PCR to rule out infection in a high-risk snake

Correction: A single negative PCR does not rule out infection, particularly if the sample was collected early in the incubation period. Repeat testing at 30-day intervals for a minimum of 90 days before reclassifying a high-risk snake to moderate or low risk.

Error 3: Failing to update risk classification after a change in exposure status

Correction: Update risk classification immediately whenever a snake is exposed to a confirmed positive animal, even if the snake appears clinically normal. Document the exposure event in the record system and schedule follow-up testing.

Error 4: Treating all positive results as equivalent regardless of sample type

Correction: A positive PCR on a postmortem tissue sample has higher diagnostic certainty than a positive PCR on a whole blood sample. Consider the sample type when interpreting results and when making management decisions. Confirm positive blood results with a second test on a different sample type when possible.

Error 5: Ignoring equivocal results

Correction: Equivocal PCR results (weak positive, indeterminate, or invalid) should be treated as moderate risk until resolved. Repeat testing on a fresh sample within 7 to 14 days. If equivocal results persist, consult with the diagnostic laboratory for guidance.

Practical Implementation Steps

Step 1: Assign risk classification to every boid snake in the collection

Begin by classifying all existing snakes based on their most recent test results, exposure history, and clinical status. Use the classification system described above. Document the classification in the record system.

Step 2: Establish testing schedules based on risk classification

Low risk snakes: Test annually. Moderate risk snakes: Test every 30 days until reclassified. High risk snakes: Test at entry and at 30, 60, and 90 days post-exposure or post-clinical sign onset. Confirmed positive snakes: Test as needed for research or monitoring purposes, but do not rely on negative results to change management.

Step 3: Implement isolation protocols based on risk classification

Low risk snakes: No isolation required. Moderate risk snakes: Isolate from the general collection in a separate room or area. Use dedicated equipment. High risk snakes: Isolate in a separate room with negative air pressure if possible. Use dedicated equipment and disposable protective clothing. Confirmed positive snakes: Permanent isolation or removal from the collection.

Step 4: Train all personnel on the decision framework

Provide training to all staff who handle snakes or work in snake housing areas. Training should include how to identify risk classifications, how to implement isolation protocols, and how to document changes in classification. Review the framework annually and update as needed based on new scientific information.

Step 5: Audit the decision framework annually

Conduct an annual audit of the decision framework to identify any classification errors, missed testing intervals, or biosecurity breaches. Review the audit results with the collection manager and make adjustments to the framework as needed.

Limitations of the Decision Framework

The decision framework is based on current understanding of reptarenavirus transmission and IBD pathogenesis, but several limitations should be acknowledged.

First, the framework assumes that PCR testing has adequate sensitivity to detect infection at all stages of disease. However, PCR sensitivity may be lower during early infection or in snakes with low viral loads. Negative PCR results should be interpreted with caution, particularly in high-risk snakes.

Second, the framework does not account for species-specific differences in susceptibility or disease progression. Experimental Reptarenavirus Infection of Boa constrictor and Python regius documented species-specific responses to experimental infection (Experimental Reptarenavirus Infection of Boa constrictor and Python regius, Journal of Virology, 2021, PubMed). Boa constrictors may remain subclinical for longer periods than Python regius, which may affect the timing of testing and classification.

Third, the framework assumes that the collection has adequate space and resources to implement isolation protocols. In practice, space constraints may limit the ability to isolate moderate and high-risk snakes. In such cases, prioritize isolation of confirmed positive snakes and consider depopulation of affected enclosures.

Fourth, the framework does not address the management of snakes that are maintained for research or educational purposes. These snakes may require different management approaches based on the specific research or educational objectives.

Professional Escalation Criteria for the Decision Framework

Contact a veterinary specialist in reptile medicine or a diagnostic laboratory immediately if:

The decision framework produces conflicting recommendations for two or more snakes in the same enclosure
A snake classified as low risk develops clinical signs consistent with IBD within 30 days of a negative PCR test
Multiple snakes in the same risk category have equivocal PCR results that cannot be resolved with repeat testing
The collection manager disagrees with a classification decision and requests a second opinion

Document all escalation events in the record system, including the reason for escalation, the specialist or laboratory consulted, and the outcome of the consultation. Use this information to refine the decision framework over time.